A paradigm shift have occurred in DED management from simply lubricating and hydrating the ocular surface with artificial tears to strategies that stimulate natural production of tear constituents, maintain ocular surface epithelial health and barrier function, and inhibit the inflammatory factors that adversely impact the ability of the ocular surface and glandular epithelia to produce
Continue reading »Fredrik Källmark om behandling av torra ögon i International Journal of Ophthalmic Practice
